Medicinal Components in Edible Mushrooms on Diabetes Mellitus Treatment

Arpita Das, Chiao Ming Chen, Shu Chi Mu, Shu Hui Yang, Yu Ming Ju, Sing Chung Li

研究成果: 雜誌貢獻回顧型文獻同行評審

摘要

Mushrooms belong to the family “Fungi” and became famous for their medicinal properties and easy accessibility all over the world. Because of its pharmaceutical properties, including anti-diabetic, anti-inflammatory, anti-cancer, and antioxidant properties, it became a hot topic among scientists. However, depending on species and varieties, most of the medicinal properties became indistinct. With this interest, an attempt has been made to scrutinize the role of edible mushrooms (EM) in diabetes mellitus treatment. A systematic contemporary literature review has been carried out from all records such as Science Direct, PubMed, Embase, and Google Scholar with an aim to represents the work has performed on mushrooms focuses on diabetes, insulin resistance (IR), and preventive mechanism of IR, using different kinds of mushroom extracts. The final review represents that EM plays an important role in anticipation of insulin resistance with the help of active compounds, i.e., polysaccharide, vitamin D, and signifies α-glucosidase or α-amylase preventive activities. Although most of the mechanism is not clear yet, many varieties of mushrooms’ medicinal properties have not been studied properly. So, in the future, further investigation is needed on edible medicinal mushrooms to overcome the research gap to use its clinical potential to prevent non-communicable diseases.
原文英語
文章編號436
期刊Pharmaceutics
14
發行號2
DOIs
出版狀態已發佈 - 2月 2022

ASJC Scopus subject areas

  • 藥學科學

指紋

深入研究「Medicinal Components in Edible Mushrooms on Diabetes Mellitus Treatment」主題。共同形成了獨特的指紋。

引用此